PAF1 and pancreatic ductal adenocarcinoma: Approximately 8.33% of ducts in Pancreatic Ductal Adenocarcinomas (PDACs) showed weak PD2 staining (composite score (CS) 1–4), 66.67% moderate staining (CS 5–8), and 25% strong staining (CS 9–12).